A Study of SC-005 in Subjects With Triple Negative Breast Cancer (TNBC)
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: SC-005
Sponsor: AbbVie